Tellgen Corporation (SHE:300642)

China · Delayed Price · Currency is CNY

11.38

-0.41 (-3.48%)

Jul 22, 2026, 3:04 PM CST

-32.50% (1Y)

Market Cap	1.82B -30.9%
Revenue (ttm)	371.54M -11.2%
Net Income	-2.44M
EPS	-0.02
Shares Out	159.86M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (0.85%)
Ex-Dividend Date	May 26, 2026

Volume	4,945,959
Open	13.58
Previous Close	11.79
Day's Range	11.33 - 13.58
52-Week Range	11.23 - 32.80
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About Tellgen

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2003

Employees 683

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300642

Full Company Profile

Financial Performance

In 2025, Tellgen's revenue was 363.83 million, a decrease of -16.70% compared to the previous year's 436.78 million. Earnings were 3.59 million, a decrease of -89.61%.

Financial Statements